ERBB2 and breast carcinoma: For example, autoantibodies against HER2 and MUC1 (39, 40) have been reported in breast cancer, while NY-ESO-1 and MAGE-A autoantibodies have been used for diagnostic and prognostic purposes in lung and melanoma cancers (40).